» Articles » PMID: 31374070

Upregulation of Insulin-Like Growth Factor-1 Receptor (IGF-1R) Reverses the Inhibitory Effect of Let-7g-5p on Migration and Invasion of Nasopharyngeal Carcinoma

Overview
Journal Med Sci Monit
Date 2019 Aug 3
PMID 31374070
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Let-7 microRNAs (miRNAs) have the effects of inhibiting tumor growth and metastasis, however, the research in nasopharyngeal carcinoma (NPC) is limited. This study focused on the effects of Let-7 on NPC migration and invasion and the mechanism of action. MATERIAL AND METHODS Plasmid transfection was used to upregulate the expression levels of Let-7g-5p and insulin-like growth factor-1 receptor (IGF-1R). Cell counting kit-8 (CCK-8) assay was applied to test the cell viability. Scratch assay and Transwell assay were performed to detect the migration and invasion abilities. Bioinformatics prediction and luciferase reporter assay were used to determine and verify the downstream target genes for Let-7g-5p. Protein and mRNA were detected by western blot and real-time quantitative polymerase chain reaction (RT-qPCR), respectively. RESULTS Let-7g-5p was under-expressed in human NPC cells. Overexpression of Let-7g-5p could inhibit cell viability and inhibit the migration and invasion of SUNE1 cells. The dual-luciferase reporter assay showed that IGF-1R was a direct target gene of Let-7g-5p, which was directly regulated IGF-1R expression by 3'UTR. Let-7g-5p overexpression could inhibit the expression of IGF-1R gene, and upregulation of IGF-1R gene expression reversed the inhibitory effect of Let-7g-5p on cell viability and epithelial-mesenchymal transition processes. CONCLUSIONS Let-7g-5p is lowly expressed in NPC and it was the first to discover that IGF-1R was a target gene of let-7g-5p in NPC. Upregulation of IGF-1R reversed the inhibitory effect of Let-7g-5p on epithelial-mesenchymal transition.

Citing Articles

lncRNA TMPO antisense RNA 1 promotes the malignancy of cholangiocarcinoma cells by regulating let-7g-5p/ high-mobility group A1 axis.

Chang H, Yao Y Bioengineered. 2022; 13(2):2889-2901.

PMID: 35040749 PMC: 8973948. DOI: 10.1080/21655979.2022.2025700.


Serum Calcium Levels Before Antitumour Therapy Predict Clinical Outcomes in Patients with Nasopharyngeal Carcinoma.

Huang S, Chen Y, Tan X, Gong S, Yang X, He Q Onco Targets Ther. 2020; 13:13111-13119.

PMID: 33380801 PMC: 7767708. DOI: 10.2147/OTT.S275613.

References
1.
King A, Ahuja A, Leung S, Lam W, Teo P, Chan Y . Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck. 2000; 22(3):275-81. DOI: 10.1002/(sici)1097-0347(200005)22:3<275::aid-hed10>3.0.co;2-n. View

2.
Cullen B . Transcription and processing of human microRNA precursors. Mol Cell. 2004; 16(6):861-5. DOI: 10.1016/j.molcel.2004.12.002. View

3.
Chan A, Leung S, Ngan R, Teo P, Lau W, Kwan W . Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst. 2005; 97(7):536-9. DOI: 10.1093/jnci/dji084. View

4.
Pillai R, Bhattacharyya S, Artus C, Zoller T, Cougot N, Basyuk E . Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science. 2005; 309(5740):1573-6. DOI: 10.1126/science.1115079. View

5.
Wee J, Tan E, Tai B, Wong H, Leong S, Tan T . Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic.... J Clin Oncol. 2005; 23(27):6730-8. DOI: 10.1200/JCO.2005.16.790. View